The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression
Open accessAbstract
Retinoblastoma (RB; encoded by RB1) is a tumor suppressor that is frequently disrupted in tumorigenesis and acts in multiple cell types to suppress cell cycle progression. The role of RB in tumor progression, however, is poorly defined. Here, we have identified a critical role for RB in protecting against tumor progression through regulation of targets distinct from cell cycle control. In analyses of human prostate cancer samples, RB loss was infrequently observed in primary disease and was predominantly associated with transition to the incurable, castration-resistant state. Further analyses revealed that loss of the RB1 locus may be a major mechanism of RB disruption and that loss of RB function was associated with poor clinical outcome. Modeling of RB dysfunction in vitro and in vivo revealed that RB controlled nuclear receptor networks critical for tumor progression and that it did so via E2F transcription factor 1-mediated regulation of androgen receptor (AR) expression and output. Through this pathway, RB depletion induced unchecked AR activity that underpinned therapeutic bypass and tumor progression. In agreement with these findings, disruption of the RB/E2F/nuclear receptor axis was frequently observed in the transition to therapy resistance in human disease. Together, these data reveal what we believe to be a new paradigm for RB function in controlling prostate tumor progression and lethal tumor phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrative Genomic Profiling of Human Prostate Cancer
Taylor, B. S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E., Reva, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.026 · Cited by 3,701
Molecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278
Harvey, J. M., Clark, G. M., Osborne, C. K., & Allred, D. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1474 · Cited by 2,056
Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription
Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., & Brown, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00188-4 · Cited by 1,657
In vivo amplification of the androgen receptor gene and progression of human prostate cancer
Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinänen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., & Kallioniemi, O.-P. (1995) · Nature Genetics · doi:10.1038/ng0495-401 · Cited by 1,484
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
Montgomery, R. B., Mostaghel, E. A., Vessella, R., Hess, D. L., Kalhorn, T. F., Higano, C. S., True, L. D., & Nelson, P. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0249 · Cited by 1,419
Self-citationScher, H. I., & Sawyers, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4777 · Cited by 1,025
Emerging roles of E2Fs in cancer: an exit from cell cycle control
Chen, H.-Z., Tsai, S.-Y., & Leone, G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2696 · Cited by 1,021
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Wang, Q., Li, W., Zhang, Y., Yuan, X., Xu, K., Yu, J., Chen, Z., Beroukhim, R., Wang, H., Lupien, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.056 · Cited by 902
Varambally, S., Yu, J., Laxman, B., Rhodes, D. R., Mehra, R., Tomlins, S. A., Shah, R. B., Chandran, U., Monzon, F. A., Becich, M. J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.001 · Cited by 800
Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.
Linja, M. J., Savinainen, K., Saramäki, O. R., Tammela, T. L. J., Vessella, R. L., & Visakorpi, T. (2001) · PubMed · Cited by 774
Sun, S., Sprenger, C. C. T., Vessella, R. L., Haugk, K., Soriano, K., Mostaghel, E. A., Page, S. T., Coleman, I. M., Nguyen, H. M., Sun, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41824 · Cited by 748
Self-citationFormation of the Androgen Receptor Transcription Complex
Shang, Y., Myers, M., & Brown, M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00471-9 · Cited by 672
Wu, H., Hsieh, J., Gleave, M. E., Brown, N. M., Pathak, S., & Chung, L. W. K. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570319 · Cited by 499
Gene expression profiling predicts clinical outcome of prostate cancer
Glinsky, G. V., Glinskii, A. B., Stephenson, A. J., Hoffman, R. M., & Gerald, W. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20032 · Cited by 479
Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target
Kwok, W. K., Ling, M.-T., Lee, T.-W., Lau, T. C. M., Zhou, C., Zhang, X., Chua, C. W., Chan, K. W., Chan, F. L., Glackin, C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3785 · Cited by 468
Self-citationGenetic Origin of Mutations Predisposing to Retinoblastoma
Cavenee, W. K., Hansen, M. F., Nordenskjold, M., Kock, E., Maumenee, I., Squire, J. A., Phillips, R. A., & Gallie, B. L. (1985) · Science · doi:10.1126/science.3983638 · Cited by 359
Tailoring to RB: tumour suppressor status and therapeutic response
Knudsen, E. S., & Knudsen, K. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2401 · Cited by 344
Self-citationPhenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone
Roudier, M. P., True, L. D., Higano, C. S., Vesselle, H., Ellis, W., Lange, P., & Vessella, R. L. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00190-4 · Cited by 311
Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer
Knudsen, K. E., & Scher, H. I. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2660 · Cited by 307
Self-citationCell Cycle-Regulated Association of E2F1 and Sp1 Is Related to Their Functional Interaction
Lin, S.-Y., Black, A. R., Kostic, D., Pajovic, S., Hoover, C. N., & Azizkhan, J. C. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1668 · Cited by 261
Sellers, W. R., Rodgers, J. W., & Kaelin, W. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11544 · Cited by 250
Knudsen, K. E., Arden, K. C., & Cavenee, W. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20213 · Cited by 204
Self-citationThe retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
Bosco, E. E., Wang, Y., Xu, H., Zilfou, J. T., Knudsen, K. E., Aronow, B. J., Lowe, S. W., & Knudsen, E. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28803 · Cited by 192
Self-citationNF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth
Zhang, L., Altuwaijri, S., Deng, F., Chen, L., Lal, P., Bhanot, U. K., Korets, R., Wenske, S., Lilja, H. G., Chang, C., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080727 · Cited by 191
Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells
Krongrad, A., Wilson, C. M., Wilson, J. D., Allman, D. R., & McPhaul, M. J. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90262-q · Cited by 186
Yeap, B. B., Krueger, R. G., & Leedman, P. J. (1999) · Endocrinology · doi:10.1210/endo.140.7.6769 · Cited by 149
Davis, J. N., Wojno, K. J., Daignault, S. D., Hofer, M. D., Kuefer, R., Rubin, M. A., & Day, M. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2497 · Cited by 139
Faber, P. W., van Rooij, H. C., Schipper, H. J., Brinkmann, A. O., & Trapman, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98349-3 · Cited by 138
Shiota, M., Yokomizo, A., Tada, Y., Inokuchi, J., Kashiwagi, E., Masubuchi, D., Eto, M., Uchiumi, T., & Naito, S. (2009) · Oncogene · doi:10.1038/onc.2009.322 · Cited by 135
E2F in vivo binding specificity: Comparison of consensus versus nonconsensus binding sitesPreprint
Rabinovich, A., Jin, V. X., Rabinovich, R., Xu, X., & Farnham, P. (2008) · Genome Research · doi:10.1101/gr.080622.108 · Cited by 135
Stender, J. D., Frasor, J. M., Komm, B. S., Chang, K. C. N., Kraus, W. L., & Katzenellenbogen, B. S. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0474 · Cited by 127
Markey, M. P., Angus, S. P., Strobeck, M. W., Williams, S., Gunawardena, R. W., Aronow, B. J., & Knudsen, E. S. (2002) · PubMed · Cited by 123
Self-citationMizokami, A., Yeh, S., & Chang, C. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.1.8152432 · Cited by 121
Transcriptional Up-Regulation of the Human Androgen Receptor by Androgen in Bone Cells
Wiren, K. M., Zhang, X., Chang, C., Keenan, E. J., & ORWOLL, E. S. (1997) · Endocrinology · doi:10.1210/endo.138.6.5163 · Cited by 117
Self-citationDistinctions in the specificity of E2F function revealed by gene expression signatures
Black, E. P., Hallstrom, T. C., Dressman, H. K., West, M., & Nevins, J. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504300102 · Cited by 95
Unique Requirement for Rb/E2F3 in Neuronal Migration: Evidence for Cell Cycle-Independent Functions
McClellan, K. A., Ruzhynsky, V. A., Douda, D. N., Vanderluit, J. L., Ferguson, K. L., Chen, D., Bremner, R., Park, D. S., Leone, G., & Slack, R. S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02100-06 · Cited by 88
Sharma, A. M., Comstock, C. E. S., Knudsen, E. S., Cao, K. H., Hess-Wilson, J. K., Morey, L. M., Barrera, J. G., & Knudsen, K. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4424 · Cited by 87
Self-citationRB Loss Abrogates Cell Cycle Control and Genome Integrity to Promote Liver Tumorigenesis
Mayhew, C. N., Carter, S. L., Fox, S. R., Sexton, C. R., Reed, C. A., Srinivasan, S. V., Liu, X., Wikenheiser‐Brokamp, K. A., Boivin, G. P., Lee, J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.025 · Cited by 87
Self-citationMarkey, M. P., Bergseid, J., Bosco, E. E., Stengel, K. R., Xu, H., Mayhew, C. N., Schwemberger, S. J., Braden, W. A., Jiang, Y., Babcock, G. F., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210450 · Cited by 82
Self-citationBisphenol A facilitates bypass of androgen ablation therapy in prostate cancer
Wetherill, Y. B., Hess-Wilson, J. K., Comstock, C. E. S., Shah, S. A., Buncher, C. R., Sallans, L., Limbach, P. A., Schwemberger, S. J., Babcock, G. F., & Knudsen, K. E. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0272 · Cited by 81
Self-citationLink, K. A., Balasubramaniam, S., Sharma, A. M., Comstock, C. E. S., Godoy‐Tundidor, S., Powers, N., Cao, K. H., Haelens, A., Claessens, F., Revelo, M. P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6392 · Cited by 80
Self-citationWhitaker, L. L., Su, H., Rajasekaran, B., Knudsen, E. S., & Wang, J. Y. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4032 · Cited by 74
Self-citationWang, L. G., Johnson, E. M., Kinoshita, Y., Babb, J. S., Buckley, M. T., Liebes, L., Melamed, J., Liu, X., Kurek, R., Ossowski, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6017 · Cited by 73
Ryan, C. J., Smith, A., Lal, P., Satagopan, J. M., Reuter, V. E., Scardino, P. T., Gerald, W. L., & Scher, H. I. (2006) · Urology · doi:10.1016/j.urology.2006.04.016 · Cited by 72
Holcomb, I. N., Young, J. M., Coleman, I. M., Salari, K., Grove, D. I., Hsu, L.-I., True, L. D., Roudier, M. P., Morrissey, C. M., Higano, C. S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3810 · Cited by 72
Self-citationTranscriptional networks and cellular senescence in human mammary fibroblasts.
Hardy, K., Mansfield, L., Mackay, A., Benvenuti, S., Ismail, S., Arora, P., O'Hare, M. J., & Jat, P. S. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-05-0392 · Cited by 71
Donovan, M. J., Osman, I., Khan, F. M., Vengrenyuk, Y., Capodieci, P., Koscuiszka, M., Anand, A., Cordon‐Cardo, C., Costa, J. C., & Scher, H. I. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08747.x · Cited by 69
Mussi, P., Yu, C., O’Malley, B. W., & Xu, J. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0522 · Cited by 65
Zheng, C., Ren, Z., Wang, H., Zhang, W., Kalvakolanu, D. V., Tian, Z., & Xiao, W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4113 · Cited by 58
Cai, C., Portnoy, D. C., Wang, H., Jiang, X., Chen, S., & Balk, S. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0026 · Cited by 57
Involvement of the CDK2-E2F1 pathway in cisplatin cytotoxicity in vitro and in vivo
Yu, F. Z., Megyesi, J. K., Safirstein, R. L., & Price, P. M. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00119.2007 · Cited by 53
Libertini, S. J., Tepper, C. G., Guadalupe, M., Lü, Y., Asmuth, D. M., & Mudryj, M. M. (2005) · The Prostate · doi:10.1002/pros.20314 · Cited by 42
Schayek, H., Bentov, I., Rotem, I., Pasmanik‐Chor, M., Ginsberg, D., Plymate, S. R., & Werner, H. (2009) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2009.08.001 · Cited by 26
Tamami, M., Lindholm, P. F., & Brady, J. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24551 · Cited by 17
Cited by
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Gao, D., Vela, I., Sboner, A., Iaquinta, P. J., Karthaus, W. R., Gopalan, A., Dowling, C., Wanjala, J. N., Undvall, E. A., Arora, V. K., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.016 · Cited by 1,559
Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,090
Self-citationOser, M. G., Niederst, M. J., Sequist, L. V., & Engelman, J. A. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71180-5 · Cited by 942
Karantanos, T., Corn, P. G., & Thompson, T. C. (2013) · Oncogene · doi:10.1038/onc.2013.206 · Cited by 866
Genetics and biology of prostate cancer
Wang, G., Zhao, D., Spring, D. J., & DePinho, R. A. (2018) · Genes & Development · doi:10.1101/gad.315739.118 · Cited by 750
Metadata
- Authors
- Sharma, A., Yeow, W.-S., Ertel, A., Coleman, I., Clegg, N., Thangavel, C., Morrissey, C., Zhang, X., Comstock, C. E. S., Witkiewicz, A. K., Gomella, L., Knudsen, E. S., Nelson, P. S., & Knudsen, K. E.
- Venue
- Journal of Clinical Investigation
- Published
- 2010-12-01
- Volume
- 120
- Issue
- 12
- Pages
- 4478-4492
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1993624611
- Cited by
- 331
- References
- 57
- FWCI
- 19.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.